Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Kansas

CNS medication trials in Kansas

27 CNS medication studies are recruiting participants at sites in 11 cities across Kansas as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Kansas city with a recruiting study

By research area: Multiple Sclerosis (9), Migraine (7), Parkinson's Disease (6), Depression (4), Epilepsy (1).

Kansas City (19), Overland Park (9), Wichita (3), Roeland Park (2), Fairway (1), Hays (1), Lawrence (1), Olathe (1), Salina (1), Topeka (1), Westwood (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Kansas

Basic details from each study's public record (the 12 most recently updated of 27). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Recruiting in
    Kansas City
    Registry record
    NCT07002034 · updated
  2. Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Overland Park
    Registry record
    NCT05850689 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Kansas on ClinicalTrials.gov.

Parkinson's disease: recently updated in Kansas

  1. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Kansas City
    Registry record
    NCT07174310 · updated
  2. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    • Phase 2
    • Ages 40 to 80
    • All sexes
    Sponsor
    Neuron23 Inc.
    Recruiting in
    Kansas City
    Registry record
    NCT06680830 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Kansas on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Kansas

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fairway · Hays · Kansas City · and 6 more U.S. locations
    Registry record
    NCT03816345 · updated
  2. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Kansas City · Roeland Park
    Registry record
    NCT07299019 · updated
  3. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Zenas BioPharma (USA), LLC
    Recruiting in
    Kansas City · Roeland Park
    Registry record
    NCT07067463 · updated
  4. Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

    • Phase 2
    • Ages 18 to 60
    • All sexes
    Sponsor
    Johns Hopkins University
    Recruiting in
    Kansas City
    Registry record
    NCT07497399 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Kansas on ClinicalTrials.gov.

Epilepsy: recently updated in Kansas

  1. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Recruiting in
    Kansas City
    Registry record
    NCT05667142 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Kansas on ClinicalTrials.gov.

Migraine: recently updated in Kansas

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Overland Park
    Registry record
    NCT06972056 · updated
  2. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Overland Park · Wichita
    Registry record
    NCT07645924 · updated
  3. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Overland Park · Wichita
    Registry record
    NCT07674654 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Kansas on ClinicalTrials.gov.

Ask about studies in Kansas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call